Literatur
Palomba S, de Wilde MA, Falbo A, Koster MP, La Sala GB, Fauser BC (2015) Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update 21(5):575–592
Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS (2006) A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12(6):673–683
Arango NA, Kobayashi A, Wang Y, Jamin SP, Lee HH, Orvis GD, Behringer RR (2008) A mesenchymal perspective of Müllerian duct differentiation and regression in Amhr2-lacZ mice. Mol Reprod Dev 75(7):1154–1162
Wang J, Dicken C, Lustbader JW, Tortoriello DV (2009) Evidence for a Müllerian-inhibiting substance autocrine/paracrine system in adult human endometrium. Fertil Steril 91(4):1195–1203
Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, Catteau-Jonard S, Collier F, Baroncini M, Dewailly D, Pigny P, Prescott M, Campbell R, Herbison AE, Prevot V, Giacobini P (2016) Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun 7:10055
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
R. Popovici gibt an, dass kein Interessenkonflikt besteht.
Additional information
Redaktion
H. Fluhr, Heidelberg
M. Goeckenjan, Dresden
R. Popovici, München
B. Sonntag, Hamburg
Rights and permissions
About this article
Cite this article
Popovici, R. Hohes Anti-Müller-Hormon bei Syndrom polyzystischer Ovarien als Anzeichen für erhöhtes Frühgeburtsrisiko. Gynäkologische Endokrinologie 17, 46–47 (2019). https://doi.org/10.1007/s10304-018-0228-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10304-018-0228-5